PIK3CA anticorps (AA 292-321)
Aperçu rapide pour PIK3CA anticorps (AA 292-321) (ABIN3003534)
Antigène
Voir toutes PIK3CA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 292-321
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- Human PK3CA. This PK3CA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 292-321 amino acids from human PK3CA.
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- PIK3CA (Phosphoinositide-3-Kinase, Catalytic, alpha Polypeptide (PIK3CA))
-
Autre désignation
- PK3CA
-
UniProt
- P42336
-
Pathways
- Signalisation PI3K-Akt, Signalisation RTK, TCR Signaling, AMPK Signaling, Interferon-gamma Pathway, Signalisation TLR, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Inositol Metabolic Process, Hepatitis C, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals, VEGF Signaling
Antigène
-